Balyasny Asset Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$129K Sell
11,831
-19,508
-62% -$244K ﹤0.01% 2744
2025
Q4
$405K Buy
+31,339
New +$402K ﹤0.01% 2613
2025
Q3
Sell
-2,270,076
Closed -$40.4M 3302
2025
Q2
$40.4M Buy
2,270,076
+634,925
+39% +$11.1M 0.06% 403
2025
Q1
$29.1M Buy
1,635,151
+566,288
+53% +$12.9M 0.05% 464
2024
Q4
$31.9M Buy
1,068,863
+229,689
+27% +$4.86M 0.05% 472
2024
Q3
$13.1M Buy
839,174
+244,176
+41% +$4.43M 0.02% 820
2024
Q2
$10.2M Buy
594,998
+167,719
+39% +$2.95M 0.02% 879
2024
Q1
$6.68M Buy
427,279
+110,476
+35% +$1.62M 0.01% 1110
2023
Q4
$4.73M Sell
316,803
-792,812
-71% -$10.6M 0.01% 1137
2023
Q3
$17.9M Buy
1,109,615
+250,509
+29% +$7.22M 0.04% 612
2023
Q2
$35.7M Buy
859,106
+501,077
+140% +$31.1M 0.08% 349
2023
Q1
$21.5M Buy
+358,029
New +$28.6M 0.05% 484
2022
Q2
Sell
-37,593
Closed -$2.83M 3044
2022
Q1
$3.12M Sell
37,593
-38,373
-51% -$2.83M 0.01% 1159
2021
Q4
$5.7M Buy
75,966
+66,614
+712% +$6.69M 0.02% 810
2021
Q3
$1.09M Buy
+9,352
New +$1.41M ﹤0.01% 1310
2020
Q4
Sell
-80,588
Closed -$8.97M 1585
2020
Q3
$8.97M Sell
80,588
-280,467
-78% -$22.4M 0.07% 417
2020
Q2
$21.4M Buy
+361,055
New +$23.7M 0.19% 155
2019
Q3
Sell
-20,236
Closed -$1.28M 1455
2019
Q2
$1.28M Buy
20,236
+9,189
+83% +$466K 0.01% 1012
2019
Q1
$532K Buy
+11,047
New +$532K ﹤0.01% 1190
2018
Q4
Sell
-9,165
Closed -$480K 1641
2018
Q3
$480K Buy
+9,165
New +$365K ﹤0.01% 1396
2018
Q2
Sell
-29,036
Closed -$633K 2039
2018
Q1
$633K Buy
+29,036
New +$625K ﹤0.01% 1379

Other funds holding NVCR